Filing Flows › International Stem Cell (ISCO) › How it makes money
How International Stem Cell (ISCO) makes money
International Stem Cell (ISCO) made $2.7M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier. Biomedical Market brought in $2.5M (94%); Anti Aging Skincare Market brought in $151K (6%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Biomedical Market | $2.5M | 94.4% | +16% | +10% |
| Anti Aging Skincare Market | $151K | 5.6% | +4% | +5% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $2.7M | 100.0% |
| Operating cash flow | $167K | 6.2% |
| Free cash flow | $160K | 6.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $2.7M | +9% |
| Q1 2026 | $2.3M | +9% |
| Q4 2025 | $2.2M | -12% |
| Q3 2025 | $2.4M | +9% |
| Q2 2025 | $2.4M | +5% |
| Q1 2025 | $2.1M | 0% |
| Q4 2024 | $2.4M | +30% |
From International Stem Cell's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does International Stem Cell make money?
International Stem Cell (ISCO) made $2.7M of revenue in the second quarter 2026 (Q2 2026), +9% from a year earlier. Biomedical Market brought in $2.5M (94%); Anti Aging Skincare Market brought in $151K (6%).
What is International Stem Cell's biggest business?
Biomedical Market: $2.5M in the second quarter 2026, 94% of revenue, +10% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.